Your browser doesn't support javascript.
loading
Phase 1 of an in vitro neurotoxicological pre-validation trial.
Williams, S P; Davenport-Jones, J; Egan, C; O'Hare, S; Cookson, M; McClean, R; Garle, M J; Pentreath, V; Atterwill, C K.
Afiliação
  • Williams SP; CellTox Centre, Division of Biosciences, University of Hertfordshire, College Lane, Hatfield, Herts. AL10 9AB, UK.
Toxicol In Vitro ; 8(4): 799-802, 1994 Aug.
Article em En | MEDLINE | ID: mdl-20693015
ABSTRACT
In the absence of a formal in vitro alternative model for neurotoxicity testing, the CellTox Centre, in collaboration with the University of Salford, FRAME and the EEC, has set up an initial pre-validation trial of a three-tiered scheme that was originally proposed in 1989. Using a cell battery of neuroblastomas and primary neural cultures (Tier I) and primary astrocytes (Tier III) an initial set of 20 chemicals (out of a reference set of 40 chemicals) has been assessed for neurotoxicity using a multiple end point assay system. The methods used were relatively simple, rapid and inexpensive, and the chemical end points were easily quantified. The results of the pre-validation trial have enabled us to revise the first tier of the proposed tiered system for full micro-validation.
Buscar no Google
Base de dados: MEDLINE Idioma: En Ano de publicação: 1994 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Idioma: En Ano de publicação: 1994 Tipo de documento: Article